HC Wainwright & Co. Reiterates Buy on Cyclo Therapeutics, Maintains $3 Price Target
HC Wainwright & Co. Reiterates Buy on Cyclo Therapeutics, Maintains $3 Price Target
HC Wainwright & Co.重申買入Cyclo Therapeutics,維持3美元的目標股價
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Cyclo Therapeutics (NASDAQ:CYTH) with a Buy and maintains $3 price target.
HC Wainwright分析師Swayampakula Ramakanth重申買入Cyclo Therapeutics(納斯達克:CYTH)並維持3美元的塔吉特。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。